Episode 205
Bivalent boosters for kids, long COVID study, monkeypox decline & more with Andrea Garcia, JD, MPH
AMA's Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, shares details of the FDA's authorization for COVID boosters for kids 5 to 11, early Pfizer data on the bivalent booster and a study on long COVID, plus the latest on monkeypox and Ebola. American Medical Association CXO Todd Unger hosts.
October 17, 202211m 25s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
AMA's Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, shares details of the FDA's authorization for COVID boosters for kids 5 to 11, early Pfizer data on the bivalent booster and a study on long COVID, plus the latest on monkeypox and Ebola. American Medical Association CXO Todd Unger hosts.
Topics
scotlandbivalent boostersstudyoctober 2022andrea garcialong covidpfixerugandamonkeypox declineebolafor kids